Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Molecular Therapy. Oncology
|
March 18, 2026
Dynamic regulation of BACH2 enhances CAR T cell function
Tien-Ching Chang, John M Warrington, Nathan Singh
Oncoimmunology
|
May 13, 2015
Roadblocks to success for RNA CARs in solid tumors
Nathan Singh, David M Barrett, Stephan A Grupp
Best Practice & Research. Clinical Haematology
|
October 9, 2021
Advances in CAR design
Amanda Heard, Jufang Chang, John M Warrington, et al.
Current Hematologic Malignancy Reports
|
October 18, 2017
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer
Nathan Singh, Junwei Shi, Carl H June, et al.
Science Translational Medicine
|
January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
Nathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
American Journal of Hematology
|
February 28, 2015
Combined B12 and folate deficiency presenting as an aggressive hematologic malignancy
Nathan Singh, Sohail Qayyum, Mariusz A Wasik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2010
Immunotherapy for ovarian cancer: what's next?
Lana E Kandalaft, Daniel J Powell, Nathan Singh, et al.
International Journal of Emergency Medicine
|
June 13, 2021
Predicting emergency department visits in a large teaching hospital
Nathan Singh Erkamp, Dirk Hendrikus van Dalen, Esther de Vries
STAR Protocols
|
January 6, 2023
Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures
Mehmet Emrah Selli, Jack H Landmann, Corvin Arveseth, et al.
Current Treatment Options in Oncology
|
April 22, 2016
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia
Nathan Singh, Noelle V Frey, Stephan A Grupp, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Molecular Therapy. Oncology
|
March 18, 2026
Dynamic regulation of BACH2 enhances CAR T cell function
Tien-Ching Chang, John M Warrington, Nathan Singh
Oncoimmunology
|
May 13, 2015
Roadblocks to success for RNA CARs in solid tumors
Nathan Singh, David M Barrett, Stephan A Grupp
Best Practice & Research. Clinical Haematology
|
October 9, 2021
Advances in CAR design
Amanda Heard, Jufang Chang, John M Warrington, et al.
Current Hematologic Malignancy Reports
|
October 18, 2017
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer
Nathan Singh, Junwei Shi, Carl H June, et al.
Science Translational Medicine
|
January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
Nathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
American Journal of Hematology
|
February 28, 2015
Combined B12 and folate deficiency presenting as an aggressive hematologic malignancy
Nathan Singh, Sohail Qayyum, Mariusz A Wasik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2010
Immunotherapy for ovarian cancer: what's next?
Lana E Kandalaft, Daniel J Powell, Nathan Singh, et al.
International Journal of Emergency Medicine
|
June 13, 2021
Predicting emergency department visits in a large teaching hospital
Nathan Singh Erkamp, Dirk Hendrikus van Dalen, Esther de Vries
STAR Protocols
|
January 6, 2023
Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures
Mehmet Emrah Selli, Jack H Landmann, Corvin Arveseth, et al.
Current Treatment Options in Oncology
|
April 22, 2016
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia
Nathan Singh, Noelle V Frey, Stephan A Grupp, et al.
Page
of 6